ATXS vs NKE · rev $706.0K vs P/E 35, rev $46.40B
Astria Therapeutics Inc (ATXS) versus Nike Inc (NKE) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by Elliott J. Hill.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported NKE revenue for 2026-05-31 was $46.40B. Net income was $3.11B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
ATXS currently screens at market cap $382.1M. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Not investment advice. Open the ATXS and NKE stock pages for the full models.
Not investment advice.